Tarsus Pharmaceuticals TARS
NASDAQ TARS
$75.46 -3.15 (-4.01%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tarsus Pharmaceuticals (TARS) Cash from Financing Activities (2019 - 2026)

Updated

Tarsus Pharmaceuticals (TARS) recorded Cash from Financing Activities of $3.3 million in Q2 2026, up 69.2% from $1.95 million a year earlier and up 174.3% from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Cash from Financing Activities (2019 - 2026) Analysis & Trends

On a TTM basis, Tarsus Pharmaceuticals' Cash from Financing Activities came in at $9.38 million as of Jun 30, 2026, down 93.4% year-over-year; for FY2025, it was $143.39 million, down 7.3% from FY2024.

  • Annual Cash from Financing Activities has a five-year compound annual growth rate of 1.7% (FY2020 to FY2025).
  • Across earlier years, Cash from Financing Activities came in at $154.66 million in FY2024 (+18.8%), $130.18 million in FY2023 (+38.5%), $93.99 million in FY2022 and $21,000 in FY2021 (-100.0%).
  • The Q2 2026 figure is the highest quarterly Cash from Financing Activities since Q1 2025.
  • On a year-over-year basis, Cash from Financing Activities rose in three of the last eight quarters, with an average decline of 0.6%.
  • Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 300.9% in Q3 2025, against a decline of 99.8% in Q3 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.2 million (Q1 2026), $2.31 million (Q4 2025) and $2.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Tarsus Pharmaceuticals 3.40 Bn 2.35 Bn 161.80 Mn 3.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.30 Mn
Mar 31, 2026 1.20 Mn
Dec 31, 2025 2.31 Mn
Sep 30, 2025 2.56 Mn
Jun 30, 2025 1.95 Mn
Mar 31, 2025 136.56 Mn
Dec 31, 2024 2.93 Mn
Sep 30, 2024 639,000.00
Jun 30, 2024 42.32 Mn
Mar 31, 2024 108.77 Mn
Dec 31, 2023 19.76 Mn
Sep 30, 2023 104.89 Mn
Jun 30, 2023 510,000.00
Mar 31, 2023 5.01 Mn
Dec 31, 2022 264,000.00
Sep 30, 2022 -136,000.00
Jun 30, 2022 74.73 Mn
Mar 31, 2022 19.13 Mn
Dec 31, 2021 -74,000.00
Sep 30, 2021 75,000.00
API Access

Tarsus Pharmaceuticals Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=TARS&period=max&api_key=YOUR_API_KEY